Neighborhood Disparities in Access to Live Donor Liver Transplant
Overview
This study investigates the impact of neighborhood segregation on access to live donor liver transplant (LDLT) among patients. It highlights significant disparities in LDLT access based on residential segregation and racial/ethnic composition, emphasizing the need for targeted interventions.
Background
Access to liver transplantation, particularly LDLT, is crucial for patients with liver disease, yet significant disparities exist based on social determinants of health. Racial and ethnic minorities often face barriers that limit their access to transplant services, exacerbating health inequities. Understanding the role of neighborhood segregation in these disparities is essential for improving access to life-saving treatments.
Data Highlights
The study utilized data from the Scientific Registry of Transplant Recipients (SRTR) to analyze access to LDLT among patients in high versus low segregation neighborhoods.
Key Findings
Increased segregation in both patient and transplant center neighborhoods correlates with lower access to LDLT.
Patients from high-segregation neighborhoods are less likely to receive LDLT compared to those from low-segregation neighborhoods.
Disparities in LDLT access vary by race and ethnicity, with minoritized groups facing greater barriers.
Insurance type also influences access to LDLT, with variations observed across different demographic groups.
Neighborhood segregation affects not only patient access but also the live donor pool available for LDLT.
Clinical Implications
Healthcare providers should be aware of the impact of neighborhood segregation on access to LDLT and advocate for policies that address these disparities. Enhancing community resources and support networks may improve health-seeking behaviors among marginalized populations.
Conclusion
Addressing the structural factors contributing to disparities in LDLT access is critical for improving outcomes for patients in high-segregation neighborhoods. Targeted interventions are necessary to ensure equitable access to this life-saving treatment.
by Alexandra T. Strauss, Gayathri Menon, Yiting Li, Valerie L. Thompson, Vedant Jain, Jane J. Long, Byoungjun Kim, Mario P. DeMarco, Babak J. Orandi, Dorry L. Segev, Mara A. McAdams-DeMarco